Meyahealth
Home
ENES
HomeGeneticsGeneIKBKG gene
Back to Gene

IKBKG gene

Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

IKBKG gene

The IKBKG gene encodes a regulatory subunit of the IKK protein complex, which is essential for activating nuclear factor-kappa-B and managing immune and inflammatory responses.

Normal Function

The IKBKG gene provides instructions for producing a subunit of the IKK protein complex, which regulates the activity of nuclear factor-kappa-B. This protein complex binds to DNA to control the activity of other genes. In a resting state, nuclear factor-kappa-B is bound to the IKK complex. When activated, the IKBKG protein triggers the IKK complex to release nuclear factor-kappa-B, which then moves into the cell nucleus to regulate genes involved in immune responses and inflammation.

Nuclear factor-kappa-B also plays a critical role in the formation of ectodermal tissues—including skin, hair, teeth, and sweat glands—and protects cells from self-destruction (apoptosis).

Health Conditions Related to Genetic Changes

Anhidrotic ectodermal dysplasia with immune deficiency

Variants in the IKBKG gene cause anhidrotic ectodermal dysplasia with immune deficiency (EDA-ID). This condition is characterized by abnormal development of ectodermal tissues and immune system dysfunction, leading to frequent infections. These variants impair the IKBKG protein's ability to regulate nuclear factor-kappa-B without completely eliminating it. Severity depends on the amount of functional protein present. Some individuals may also experience osteopetrosis (unusually dense bones) and lymphedema (swelling of soft tissues), a presentation sometimes called OL-EDA-ID.

Incontinentia pigmenti

Variants in the IKBKG gene are identified in people with incontinentia pigmenti, a condition involving skin, tooth, and nail abnormalities, as well as an increased risk of stroke and vision loss. The most common variant is a deletion that leads to a nonfunctional protein. Without functional IKBKG, nuclear factor-kappa-B cannot be activated, making cells more sensitive to signals that trigger apoptosis. This abnormal cell death leads to the condition's symptoms.

Other disorders

IKBKG gene variants can cause X-linked susceptibility to mycobacterial disease. These variants alter the structure of the IKBKG protein, disrupting signaling pathways in immune cells. Consequently, affected individuals have immune cells that function poorly and cannot effectively defend the body against mycobacteria, such as the bacteria that cause tuberculosis.

Genomic Location

The IKBKG gene is found on the X chromosome.

Frequently Asked Questions

Diagnosis typically combines clinical evaluation (skin, hair, teeth, recurrent infections) with molecular testing. A blood sample is sent for targeted sequencing or deletion/duplication analysis of the IKBKG gene. In some labs, multiplex ligation‑dependent probe amplification (MLPA) is added to detect the common exon 4 deletion. Functional assays, such as measuring NF‑κB activation in patient‑derived cells, can support pathogenicity when genetic results are ambiguous.
Management is multidisciplinary. Prophylactic antibiotics (e.g., trimethoprim‑sulfamethoxazole) and antifungal agents reduce infection risk. Immunoglobulin replacement therapy (IVIG or subcutaneous Ig) is often started once antibody deficiency is documented. Hematopoietic stem cell transplantation (HSCT) from a matched donor can reconstitute immune function, but success depends on the residual IKBKG activity; reduced‑intensity conditioning regimens are preferred to limit toxicity.
Because IKBKG is X‑linked, heterozygous females may show mild ectodermal features (sparse hair, dental anomalies) or occasional infections due to skewed X‑inactivation. Carrier testing is recommended for mothers and sisters of affected individuals. If a carrier has symptoms, a baseline immunologic work‑up (CBC, immunoglobulins, vaccine response) is prudent, and she should be counseled about the risk of passing the mutation to offspring.
Key red flags include fever lasting >38 °C for more than 24 hours, rapid breathing, lethargy, or a new skin lesion that looks infected. Because these children have impaired immune responses, even seemingly mild infections (e.g., otitis media or a diaper rash) can progress quickly to sepsis. Prompt evaluation and empiric antibiotics are advised whenever systemic symptoms appear.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.